We may not be able to unveil our 2020 Visions #KIimages tonight, but we can give you a (safe and socially-distanced) peek at our new images.
Far right: "Cloak and Swagger: Learning from the Enemy"
2nd to right: "20,000 Nanoleagues Under the SEM: Exploring the Power Within"
To dream the impossible dream.....
To drug the impossible #cancer drug target
KRAS (the most frequently mutated oncogene w/o a therapy)
https://t.co/qhJKCxCgBG @PNASNews by @DKessle25077240 @Boehringer@VUmedicine will be interested in @Dereklowe & @rplenge's take on this
#GapSummit2019 has been amazing! Great people, great talks and great discussions! And our Team ActioTherme with my amazing team members @NacOfAllTrades @HASCiencia@Arnav_Chhabra & @patrlundgren came 2nd in the Voices of Tomorrow competition! 😄
In 2012, Ivacaftor developed by Vertex became the first drug to treat the cause rather than symptoms of cystic fibrosis. Now the structure of the drug bound to its target, the ion channel CFTR, has finally been cracked by the Chen lab at Rockefeller. https://t.co/uXIR0mkS6A